Viatris and Medical Learning Hub warmly welcome you to an interactive online case study on Drug-Resistant Tuberculosis (DRTB). This course has been developed under the expert guidance of Dr. Vikas Oswal, National Technical Expert Member, NTEP (India), Governor of Maharashtra for the Chest Council of India, and Chairperson of DRTB Sites, Govandi, Mumbai.
Designed to provide a valuable learning experience, this course offers comprehensive insights into the challenges of managing DRTB while incorporating the latest updates on TB treatment guidelines. Join us to enhance your clinical knowledge and stay updated with the evolving landscape of drug-resistant tuberculosis care.
Case Learning Objectives:
This course aims to provide a deeper understanding of the application of Pretomanid within the BPaL and BPaL M regimens, highlighting its role in advancing drug-resistant TB treatment.
Participants will learn how to effectively manage relapse and resistance in TB patients, ensuring better clinical outcomes.
The course also emphasizes the importance of integrating family history into treatment planning, fostering a more holistic and personalized approach to TB management.
Additionally, it will enable healthcare professionals to evaluate the benefits of different treatment regimens and their impact on patient outcomes.
Join us for this essential learning experience and enhance your expertise in managing drug-resistant TB with the latest DRTB guidelines. Register now!
This course provides a comprehensive understanding of the latest TB diagnosis and treatment protocols, with a focus on the BPaL and BPaL M regimens, which offer shorter, all-oral treatment options for drug-resistant TB.
You will gain valuable insights into the benefits of these updated regimens, including improved efficacy, reduced treatment duration, and strategies to enhance patient adherence.
The course will also explore multidrug-resistant TB (MDR-TB) management, addressing key challenges and advancements through the implementation of the shorter BPaL & BPaL M regimens.
Practical case studies will illustrate real-world applications of these treatments, while engaging infographics will simplify complex guidelines. To reinforce learning, interactive polls and quizzes will provide an opportunity to test your knowledge and encourage active participation, making the learning experience both informative and engaging.
This course holds immense educational value by providing a comprehensive understanding of Drug-Resistant Tuberculosis (DRTB) management, including the latest updates on treatment protocols and evolving therapeutic strategies.
It emphasizes the clinical relevance of emerging regimens, particularly the role of Pretomanid in the innovative BPaL and BPaL M treatment approaches.
By exploring these advancements, the course offers valuable insights into newer, more effective treatment strategies, equipping healthcare professionals with the knowledge to optimize patient care and improve treatment outcomes.
Indian healthcare professionals including:
- Pulmonologist (chest physicians)
- Respiratory medicine specialist
- General physicians
